Company Profiles

driven by the PitchBook Platform

Zyngenia

Description

Developer of multi-specific antibody-based drugs in the United States. The company focuses on the development of therapies for various cancers and autoimmune disorders.

2008

Founded

PRIVATE

Status

11-50

Employees

Early Stage VC

Latest Deal Type

$10M

Latest Deal Amount

$40M

Total Amount Raised

Description

Developer of multi-specific antibody-based drugs in the United States. The company focuses on the development of therapies for various cancers and autoimmune disorders.

Website:

www.zyngenia.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Drug Discovery

Primary Office

P.O. Box 3130 Gaithersburg, MD 20878United States +1 (301) 453-0100
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Zyngenia's full profile, request a free trial.

    Zyngenia Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Zyngenia Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Zyngenia Investors (2)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Montgomery County Environmental SolutionsPE/BuyoutMinority000 0000000 0000
    New Enterprise AssociatesVenture CapitalMinority000 0000000 0000
    Montgomery County Environmental Solutions PE/Buyout
    New Enterprise Associates Venture Capital

    Zyngenia Executive Team (4)

    NameTitleBoard
    Seat
    Contact
    Info
    David Hilbert Ph.DChief Scientific Officer & Head, Research & Development
    Viktor RoschkeVice President, Biopharmaceutical Research & Assay Development
    Carlos Barbas IIIFounder
    David Parkinson MDActing Chief Executive Officer & Board Member
    David Hilbert Ph.D Chief Scientific Officer & Head, Research & Development
    Viktor Roschke Vice President, Biopharmaceutical Research & Assay Development
    Carlos Barbas III Founder
    David Parkinson MD Acting Chief Executive Officer & Board Member

    Zyngenia Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    Christian Itin Ph.DSelfBoard Member000 0000
    David MottNew Enterprise AssociatesGeneral Partner000 0000
    David Parkinson MDSelfActing Chief Executive Officer & Board Member000 0000
    Robert Garland MDNew Enterprise AssociatesVenture Partner000 0000
    Sara Nayeem MDNew Enterprise AssociatesPartner000 0000
    Christian Itin Ph.D Board Member Self
    David Mott General Partner New Enterprise Associates
    David Parkinson MD Acting Chief Executive Officer & Board Member Self
    Robert Garland MD Venture Partner New Enterprise Associates
    Sara Nayeem MD Partner New Enterprise Associates
    Request full access to PitchBook